Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-06 08:47 am Purchase | 13G | NUVECTIS PHARMA INC NVCT | Pontifax Management 4 G.P. (2015) Ltd. | 917,400 5.3% | 917,400 (New Position) | View |
| 2020-04-23 4:00 pm Purchase | 13D | KEROS THERAPEUTICS INC KROS | Pontifax Management 4 G.P. (2015) Ltd. | 4,734,507 23.6% | 4,734,507 (New Position) | View |
| 2019-09-19 12:47 pm Purchase | 13D | ARQULE INC ARQL | Pontifax Management 4 G.P. (2015) Ltd. | 8,844,587 7.35% | 452,587 (+5.39%) | View |